Clearance of extracellular misfolded proteins in systemic amyloidosis: Experience with transthyretin

FEBS Letters

Volumn 586, Issue 18, 2012, Pages 2891-2896

  Almeida, Maria Rosário ^a,b   Saraiva, Maria João ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Amyloid; Clusterin; Doxycycline; EGCG (epigallocatechin gallate); Transthyretin

Indexed keywords

4' IODOESORUBICIN; AMYLOID; CHAPERONE; CLUSTERIN; CURCUMIN; DOXYCYCLINE; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; METALLOPROTEINASE; OLIGOMER; PREALBUMIN; PROTEIN; TAURODEOXYCHOLIC ACID; TETRACYCLINE;

AMYLOIDOSIS; CLEARANCE; CONFERENCE PAPER; DEGENERATIVE DISEASE; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SCREENING; FAMILIAL AMYLOID POLYNEUROPATHY; HEAT SHOCK RESPONSE; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MISFOLDING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SYSTEMIC SENILE AMYLOIDOSIS; TRANSGENIC MOUSE; TREATMENT DURATION;

AMYLOIDOSIS; ANIMALS; DOXYCYCLINE; MICE; MICE, TRANSGENIC; PREALBUMIN; PROTEIN FOLDING;

MUS MUSCULUS;

EID: 84864931018     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.07.029     Document Type: Conference Paper

References (44)

1. K. Bodin, S. Ellmerich, M.C. Kahan, G.A. Tennent, A. Loesch, J.A. Gilbertson, W.L. Hutchinson, P.P. Mangione, J.R. Gallimore, D.J. Millar, S. Minogue, A.P. Dhillon, G.W. Taylor, A.R. Bradwell, A. Petrie, J.D. Gillmore, V. Bellotti, M. Botto, P.N. Hawkins, and M.B. Pepys Antibodies to human serum amyloid P component eliminate visceral amyloid deposits Nature 468 7320 2010 93 97
2. H. Terazaki, Y. Ando, R. Fernandes, K. Yamamura, S. Maeda, and M.J. Saraiva Immunization in familial amyloidotic polyneuropathy: Counteracting deposition by immunization with a Y78F TTR mutant Lab. Invest. 86 2006 23 31
3. M.M. Sousa, and M.J. Saraiva Neurodegeneration in familial amyloidotic polyneuropathy: from pathology to molecular signaling Prog. Neurobiol. 71 2003 385 400
4. R. Alvarez, T. Borland, Q. Chen, S. Nilstein, T. Nguyen, G. Hinkle, S. Kuchimanchi, J. Costigan, V. Ristoiu, G. Wang, G. Cole, R. Dorkin, A. Akinc, L. Nechev, V. Kosovrasti, L. Tchangov, M. Tracy, L. Jeffs, I. MaqLachlan, P. Lutwyche, D. Martins, S. Costelha, M.J. Saraiva, and D.W.Y. Sah ALN-TTR, an RNAi therapeutic for the treatment of transthyretin-mediated amyloidosis. Amyloid J. Protein Fold. Disord. 17 Supplement 2010 51
5. Coelho, T., Maia, L.F., Silva, A.M., Cruz, M.W., Plante-Bordeneuve, V., Lozeron, P., Suhr, O.B., Campistol, J.M., Conceição, I.M., Schmidt, H.H-J., Trigo, P., Kelly, J.W., Labaudinière, Chan, J., Packman, J., Wilson, A., Grogan, D.R. (2011). Tafamidis for transthyretin familial amyloid polyneuropathy. A randomized, controlled trial, Neurology, in press.
6. S.D. Santos, J. Magalhães, and M.J. Saraiva Activation of the heat shock response in familial amyloidotic polyneuropathy J. Neuropathol. Exp. Neurol. 67 2008 449 455
7. S.D. Santos, R. Fernandes, and M.J. Saraiva The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems Neurobiol. Aging 31 2 2010 280 289
8. S. Poon, S.B. Easterbrook-Smith, and M.S. Rybchyn Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state Biochemistry 39 51 2000 15953 15960
9. D.T. Humphreys, J.A. Carver, and S.B. Easterbrook-Smith Clusterin has chaperone-like activity similar to that of small heat shock proteins J. Biol. Chem. 274 11 1999 6875 6881
10. M.R. Wilson, and S.B. Easterbrook-Smith Clusterin is a secreted mammalian chaperone Trends Biochem. Sci. 25 3 2000 95 98
11. D. Michel, G. Chatelain, and S. North Stress-induced transcription of the clusterin/apoJ gene Biochem. J. 328 Pt 1 1997 45 50
12. J.J. Yerbury, S. Poon, and S. Meehan The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures FASEB J. 21 10 2007 2312 2322
13. E. Matsubara, C. Soto, and S. Governale Apolipoprotein J and Alzheimer's amyloid beta solubility Biochem. J. 316 Pt 2 1996 671 679
14. J.J. Yerbury, and M.R. Wilson Extracellular chaperones modulate the effects of Alzheimer's patient cerebrospinal fluid on Abeta(1-42) toxicity and uptake Cell Stress Chaperones 15 1 2010 115 121
15. A.R. Wyatt, J.J. Yerbury, P. Berghofer, I. Greguric, A. Katsifis, C.M. Dobson, and M.R. Wilson Clusterin facilitates in vivo clearance of extracellular misfolded proteins Cell. Mol. Life Sci. 68 23 2011 3919 3931
16. J. Magalhães, and M.J. Saraiva Clusterin overexpression and putative role in transthyretin deposition in familial amyloidotic polyneuropathy J. Neurop. Exp. Neurol. 70 2011 1097 1106
17. G. Merlini, E. Ascari, N. Amboldi, V. Bellotti, E. Arbustini, V. Perfetti, M. Ferrari, I. Zorzoli, M.G. Marinone, and P. Garini Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis Proc. Natl. Acad. Sci. U S A 92 7 1995 2959 2963
18. F. Tagliavini, G. Forloni, L. Colombo, G. Rossi, L. Girola, B. Canciani, N. Angeretti, L. Giampaolo, E. Peressini, T. Awan, L. De Gioia, E. Ragg, O. Bugiani, and M. Salmona Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro J. Mol. Biol. 300 5 2000 1309 1322
19. I. Cardoso, G. Merlini, and M.J. Saraiva 4′-Iodo-4′- Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing non- cytotoxic species. Screening for TTR fibril disrupters FASEB J. 17 2003 803 809
20. I. Cardoso, M. Brito, and M.J. Saraiva Extracellular matrix markers for disease progression and follow-up of therapies in familial amyloid polyneuropathy V30M TTR-related Dis. Markers 25 2008 37 47
21. I. Cardoso, and M.J. Saraiva Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model FASEB J. 20 2006 234 239
22. S. Giorgetti, S. Raimondi, K. Pagano, A. Relini, M. Bucciantini, A. Corazza, F. Fogolari, L. Codutti, M. Salmona, P. Mangione, L. Colombo, A. De Luigi, R. Porcari, A. Gliozzi, M. Stefani, G. Esposito, V. Bellotti, and M. Stoppini Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils J. Biol. Chem. 286 3 2011 2121 2131
23. J.E. Ward, R. Ren, G. Toraldo, P. Soohoo, J. Guan, C. O'Hara, R. Jasuja, V. Trinkaus-Randall, R. Liao, L.H. Connors, and D.C. Seldin Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis Blood 118 2011 6610 6617
24. A. Quintas, D.C. Vaz, I. Cardoso, M. Saraiva, and R.M. Brito Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants J. Biol. Chem. 276 2001 27207 27213
25. M.R. Almeida, L. Gales, A.M. Damas, I. Cardoso, and M.J. Saraiva Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses Curr. Drug Targets CNS Neurol. Disord. 5 2005 587 596
26. S.M. Johnson, R.L. Wiseman, Y. Sekijima, N.S. Green, S.L. Adamski-Werner, and J.W. Kelly Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses Acc. Chem. Res. 38 12 2005 911 921
27. D.E. Ehrnhoefer, J. Bieschke, A. Boeddrich, M. Herbst, and L. Masino EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15 6 2008 558 566
28. T. Liu, and G. Bitan Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms ChemMedChem 5,7 3 2012 359 374
29. J. Bieschke, J. Russ, R.P. Friedrich, D.E. Ehrnhoefer, H. Wobst, K. Neugebauer, and E.E. Wanker EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity Proc. Natl. Acad. Sci. U S A 107 17 2010 7710 7715
30. N. Ferreira, I. Cardoso, M.R. Domingues, R. Vitorino, M. Bastos, G. Bai, M.J. Saraiva, and M.R. Almeida Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity FEBS Lett. 583 2009 3569 3576
31. R. Pullakhandam, P.N. Srinivas, M.K. Nair, and G.B. Reddy Binding and stabilization of transthyretin by curcumin Arch. Biochem. Biophys. 485 2 2009 115 119
32. M. Miyata, T. Sato, M. Kugimiya, M. Sho, T. Nakamura, S. Ikemizu, M. Chirifu, M. Mizuguchi, Y. Nabeshima, Y. Suwa, H. Morioka, T. Arimori, M.A. Suico, T. Shuto, Y. Sako, M. Momohara, T. Koga, S. Morino-Koga, Y. Yamagata, and H. Kai The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site Biochemistry 49 29 2010 6104 6114
33. N. Ferreira, M.J. Saraiva, and M.R. Almeida Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation FEBS Lett. 585 15 2011 2424 2430
34. N. Ferreira, M.J. Saraiva, and M.R. Almeida Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: in vivo evidence from FAP mice models PLoS One 7 1 2012 e29933
35. W. Hunstein Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option? Blood 110 6 2007 2216
36. D. Mereles, S.J. Buss, S.E. Hardt, W. Hunstein, and H.A. Katus Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis Clin. Res. Cardiol. 99 8 2010 483 490
37. A.V. Kristen, S. Lehrke, S. Buss, D. Mereles, H. Steen, P. Ehlermann, S. Hardt, E. Giannitsis, R. Schreiner, U. Haberkorn, P.A. Schnabel, R.P. Linke, C. Röcken, E. Wanker, T.J. Dengler, K. Altland, and H.A. Katus Green tea halts progression of cardiac transthyretin amyloidosis: an observational report Clin. Res. Cardiol. 2012 [Epub ahead of print]
38. S. Mandel, and M.B. Youdim Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases Free Radic. Biol. Med. 37 3 2004 304 317
39. S. Sinha, D.H. Lopes, Z. Du, E.S. Pang, A. Shanmugam, A. Lomakin, P. Talbiersky, A. Tennstaedt, K. McDaniel, R. Bakshi, P.Y. Kuo, M. Ehrmann, G.B. Benedek, J.A. Loo, F.G. Klärner, T. Schrader, and C. Wang Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins J. Am. Chem. Soc. 26,133 42 2011 16958 16969
40. C.D. Keene, C.M. Rodrigues, T. Eich, M.S. Chhabra, C.J. Steer, and W.C. Low Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease Proc. Natl. Acad. Sci. U S A 99 16 2002 10671 10676
41. M.M. Sousa, S.D. Yan, R. Fernandes, A. Guimarães, D. Stern, and M.J.M. Saraiva Familial amyloid polyneuropathy: RAGE-dependent triggering of neuronal inflammatory and apoptotic pathways J. Neurosci. 21 2001 7576 7586
42. B. Macedo, A.R. Batista, N. Ferreira, M.R. Almeida, and M.J. Saraiva Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy Biochem. Biophys. Acta 1782 9 2008 517 522
43. I. Cardoso, D. Martins, T. Ribeiro, G. Merlini, and M.J. Saraiva Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models J. Transl. Med. 8 2010 74 78
44. L. Obici, A. Cortese, A. Lozza, J. Lucchetti, M. Gobbi, G. Palladini, S. Perlini, M.J. Saraiva, and G. Merlini Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study Amyloid 19 Suppl. 1 2012 34 36